Early Insights From Clinical Trials of Typhoid Conjugate Vaccine
AUTHORS
Neuzil
KM ,
Basnyat
B ,
Clemens
JD ,
Gordon
MA ,
Patel
PD ,
Pollard
AJ ,
Shakya
M ,
Qadri
F ,
. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. ; 71(Supplement_2). S155-S159
- PMID: 32725230 [PubMed].
ABSTRACT
Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.
Tags: alumni publications 2020